Literature DB >> 21170875

Urinary pH and stone formation.

Carsten A Wagner1, Nilufar Mohebbi.   

Abstract

The formation of various types of kidney stones is strongly influenced by urinary pH. An alkaline pH favors the crystallization of calcium- and phosphate-containing stones, whereas and acidic urine pH promotes uric acid or cystine stones. The activity of many transport processes involved in calcium, citrate and phosphate handling are sensitive to changes in systemic or local pH as shown for several phosphate transporters, the citrate transporter NaDC1 and the TRPV5 calcium channel. Defects in urinary acidification (excretion of inappropriately alkaline or acidic urines, respectively) contribute to kidney stone disease. The low excretion of ammonium in patients with metabolic syndrome has been linked to more acidic urine and a higher incidence of uric acid stones. In this state, insulin resistance may reduce ammonium excretion by the proximal tubule. On the other hand, defensive mechanisms may protect from kidney stone formation in conditions such as hypercalciuria where high luminal calcium concentrations stimulate urinary acidification and reduce urinary concentration via a calcium-sensing receptor, resulting in the excretion of acidic and diluted urine. This review will discuss a few aspects that relate to the capacity of the kidney to regulate pH and its impact on the excretion of solutes that participate in the formation or prevention of stones.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21170875

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  37 in total

1.  Update on the evaluation of repeated stone formers.

Authors:  Adam O Kadlec; Thomas M Turk
Journal:  Curr Urol Rep       Date:  2013-12       Impact factor: 3.092

Review 2.  Ammonia Transporters and Their Role in Acid-Base Balance.

Authors:  I David Weiner; Jill W Verlander
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

3.  Parsley! Mechanism as antiurolithiasis remedy.

Authors:  Fayed Al-Yousofy; Hussein Gumaih; Hassan Ibrahim; Afrah Alasbahy
Journal:  Am J Clin Exp Urol       Date:  2017-11-09

4.  Diabetes mellitus and the risk of urolithiasis: a meta-analysis of observational studies.

Authors:  Lu Hao Liu; Ran Kang; Jun He; Shan Kun Zhao; Fu Tian Li; Zhi Gang Zhao
Journal:  Urolithiasis       Date:  2015-04-17       Impact factor: 3.436

5.  Novel Risk Loci Identified in a Genome-Wide Association Study of Urolithiasis in a Japanese Population.

Authors:  Chizu Tanikawa; Yoichiro Kamatani; Chikashi Terao; Masayuki Usami; Atsushi Takahashi; Yukihide Momozawa; Kichiya Suzuki; Soichi Ogishima; Atsushi Shimizu; Mamoru Satoh; Keitaro Matsuo; Haruo Mikami; Mariko Naito; Kenji Wakai; Taiki Yamaji; Norie Sawada; Motoki Iwasaki; Shoichiro Tsugane; Kenjiro Kohri; Alan S L Yu; Takahiro Yasui; Yoshinori Murakami; Michiaki Kubo; Koichi Matsuda
Journal:  J Am Soc Nephrol       Date:  2019-04-11       Impact factor: 10.121

6.  Comparison of body condition score and urinalysis variables between dogs with and without calcium oxalate uroliths.

Authors:  Stephanie M Kennedy; Jody P Lulich; Michelle G Ritt; Eva Furrow
Journal:  J Am Vet Med Assoc       Date:  2016-12-01       Impact factor: 1.936

Review 7.  Prevalence, pathophysiological mechanisms and factors affecting urolithiasis.

Authors:  Aslam Khan
Journal:  Int Urol Nephrol       Date:  2018-03-22       Impact factor: 2.370

Review 8.  Contemporary best practice urolithiasis in pregnancy.

Authors:  Marie-Therese I Valovska; Vernon M Pais
Journal:  Ther Adv Urol       Date:  2018-02-08

Review 9.  Simplified methods for the evaluation of the risk of forming renal stones and the follow-up of stone-forming propensity during the preventive treatment of stone-formation.

Authors:  Fèlix Grases; Antonia Costa-Bauzá
Journal:  Urolithiasis       Date:  2015-11-27       Impact factor: 3.436

10.  Lessons of the month: Over-the-counter antacids causing hypercalcaemia: The emergence of calcium-alkali syndrome.

Authors:  Amro Maarouf; Sharon Jones
Journal:  Clin Med (Lond)       Date:  2020-07       Impact factor: 2.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.